Resource > Webinars >
From Dose to Circulation: Determination of Drug Oral Bioavailability Using a Gut-Liver Microphysiological System
Determination of Drug Oral Bioavailability Using a Gut-Liver Microphysiological System
Filed under: ADME and Drug bioavailability
Video content if present
From Dose to Circulation
Determination of Drug Oral Bioavailability Using a Gut-Liver Microphysiological System
Watch this webinar to learn:
- Learn how bioavailability can be determined in vitro using human cells
- Discover how gut-liver MPS can be used to evaluate a key ADME parameter
- Discuss the application of mathematical modeling to predict oral bioavailability
In this webinar, Dr. Yassen Abbas discusses how CN Bio’s gut-liver MPS can be used for in vitro determination of oral bioavailability. This application has been validated with drugs with known human bioavailability and with a mathematical model developed to enable prediction of oral bioavailability in silico.
Bioavailability is a key parameter of a drug’s behaviour and is determined during pre-clinical development. It is the fraction of a compound that reaches systemic circulation and is important for efficacy and safety considerations. Bioavailability estimations to date have relied heavily on animal models. However, these models are expensive and have limited relevance to humans.
View our Q&A document from the live event.
Speaker Information:
Dr Yassen Abbas
Senior Scientist
CN Bio